Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.

about

Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection.

P2860

Q40041686-F55E5EB6-3FC4-44E0-82B9-E19D0B631ADE

P2860

Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.

Item

http://www.wikidata.org/entity/Q38684877

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Suggested new breakpoints of a ...... e analysis of serologic tests.

@en

type

Item

label

Suggested new breakpoints of a ...... e analysis of serologic tests.

@en

prefLabel

Suggested new breakpoints of a ...... e analysis of serologic tests.

@en

P1476

Suggested new breakpoints of a ...... e analysis of serologic tests.

@en

P2093

C Drosten

http://www.w3.org/2001/XMLSchema#string

C R Chung

http://www.w3.org/2001/XMLSchema#string

C-I Kang

http://www.w3.org/2001/XMLSchema#string

D R Chung

http://www.w3.org/2001/XMLSchema#string

E-S Kang

http://www.w3.org/2001/XMLSchema#string

G E Park

http://www.w3.org/2001/XMLSchema#string

H Seok

http://www.w3.org/2001/XMLSchema#string

I J Jo

http://www.w3.org/2001/XMLSchema#string

J Y Baek

http://www.w3.org/2001/XMLSchema#string

J Y Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.

Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients.

Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia.

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity.

Serologic Evaluation of MERS Screening Strategy for Healthcare Personnel During a Hospital-Associated Outbreak.

Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea.

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection.

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.

P2888

s10096-017-3043-3

P31

scholarly article

P356

10.1007/S10096-017-3043-3

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090613986

http://www.w3.org/2001/XMLSchema#string

P698

28695355

http://www.w3.org/2001/XMLSchema#string

P921

Middle East respiratory syndrome coronavirus

Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.

about

P2860

P2860

Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P921